Study to Assess Safety & Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodiol.
NCT03226067
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
111
Enrollment
INDUSTRY
Sponsor class
Conditions
Primary Biliary Cirrhosis
Interventions
DRUG:
GKT137831
DRUG:
Placebo oral capsule
Sponsor
Calliditas Therapeutics AB